grants from the National Key Basic Research Program of China (No.2014CB541901); the National Nature Science Foundation of China (No.81573033); the National Key Research Program of China (No.2016YFC0906102).
Background:Systemic lupus erythematosus (SLE)is an autoimmune disease under genetic control.Growing evidences support the genetic predisposition ofHLA-DRB1 gene polymorphisms to SLE,yet the results are not often repro...
We previously reported that SM934, a water-soluble artemisinin derivative, was a viable treatment in murine lupus models. In the current study, we further investigated the therapeutic effects of a modified dosage regi...
This work was supported by grants from the National Natu- ral Science Foundation of China (No 81273524, 81273525, and 81322049) and the National Key Basic Research Program (973 Program, 2014CB541906).
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by the loss of tolerance to self-nuclear antigens. Accumulating evidence shows that Toll-like receptors (TLRs), previously proven to...